Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients. | Mediterr J Hematol Infect Dis;7(1): e2015058, 2015. | MEDLINE

Conteúdo principal 1 Busca 2 Rodapé 3

+A A -A Alto contraste

BVS - MINISTÉRIO DA SAÚDE

Informação e Conhecimento para a Saúde

português

Localizar descritor de assunto Busca Avançada EVID@Easy

Efficacy and Safety of Cladribine: Subcutaneous versus Intravenous Administration in Hairy Cell Leukemia Patients.

Khorshid, Ola; Namour, Alfred Elias; El-Gammal, Mosaad M; Mahmoud, Tarek Yakout; Fortpied, Catherine; Abdel-Malek, Raafat; Ramadan, Safaa.

Afiliação

Khorshid O; National Cancer Institute, Cairo University, Cairo, Egypt.
Namour AE; National Cancer Institute, Cairo University, Cairo, Egypt.
El-Gammal MM; National Cancer Institute, Cairo University, Cairo, Egypt.
Mahmoud TY; National Cancer Institute, Cairo University, Cairo, Egypt.
Fortpied C; National Cancer Institute, Cairo University, Cairo, Egypt.
Abdel-Malek R; Kasr Al-Ainy school of Medicine, Cairo University.
Ramadan S; National Cancer Institute, Cairo University, Cairo, Egypt.

Mediterr J Hematol Infect Dis ; 7(1): e2015058, 2015.

Article em En | MEDLINE | ID: mdl-26543527

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article